Solutions – Page 12

Disruptive Innovation in MedTech: Evolving Characteristics and Modern Realities

Disruptive innovation has long driven paradigm shifts in medical devices, transforming care delivery, access, and outcomes. In 2025, the bar now includes demonstrated clinical performance, workflow re-engineering, reimbursement alignment, and real-world evidence

October 15, 2025

Solutions

BioNTech’s African mRNA vaccine production push gets EU funding boost

As BioNTech works to establish a production footprint for mRNA vaccines in Africa, two EU groups have offered financial backing to the company’s efforts.

October 14, 2025

News·Solutions

Novo plant hit with FDA’s most serious inspection classification, portending possible delays for partners

The FDA has tagged Novo Nordisk’s newly acquired manufacturing facility in Indiana with an official action indicated label, which is the most severe of the three inspection classifications issued by the agency.

October 13, 2025

News·Solutions

Syngene: Transforming Monoclonal Antibody Manufacturing for the Next Wave of Biologics

October 13, 2025

News·Solutions

Sunrise Labs Rebrands as Suntra MedTech Solutions™

Press Release: MTI Staff was not involved in writing this content October 1, 2025 — Bedford, New Hampshire For over three decades, Sunrise Labs stood at the forefront of engineering excellence and

October 13, 2025

News·Solutions

German drug delivery specialist LTS grows US footprint with buyout of CDMO Renaissance Lakewood

Germany’s LTS—whose bread-and-butter business revolves around developing and manufacturing drug delivery systems—is paying an undisclosed sum to purchase U.S. CDMO Renaissance Lakewood, which itself specializes in nasals sprays and sterile dosage forms.

October 13, 2025

News·Solutions

Swiss auto-injector specialist Ypsomed invests $248M to build manufacturing facility in N.C.

Auto-injector specialist Ypsomed is hopping on the United States manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the first

October 10, 2025

News·Solutions

AstraZeneca kicks off construction of $4.5B API plant in Virginia

AstraZeneca has broken ground on a $4.5 billion manufacturing facility near Charlottesville, Virginia, confirming a report about its location six weeks ago when state lawmakers approved an economic development package for the

October 9, 2025

News·Solutions

Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla.

Lupin expects to invest a combined $250 million—covering R&D, infrastructure and capital expenditures over five years—to build a new pharmaceutical production plant in Coral Springs, Florida. The site will focus on the

October 9, 2025

News·Solutions

OXB kicks off US expansion, buying viral vector plant in N.C. from National Resilience for $4.5M

Less than two months after OXB revealed a plan to expand its operations in the U.S., the U.K.-based cell and gene therapy manufacturer has purchased a viral vector plant in North Carolina

October 7, 2025

News·Solutions

Solutions - Page 12